Wednesday, August 14, 2013

Exercise May Reverse Memory Loss in MCI Patients


Fran Lowry
Aug 06, 2013
 
Walking on a treadmill for 30 minutes a day 4 days a week over a 12-week period improved memory scores and neural efficiency in older people with mild cognitive impairment (MCI), according to new research.
The finding suggests that exercise may protect against or delay conversion to Alzheimer's disease in at-risk individuals.
"We found that after just 12 weeks of being on a moderate exercise program, participants improved their neural efficiency; they were using fewer neural resources to perform the same memory task," J. Carson Smith, PhD, from the University of Maryland in College Park, told Medscape Medical News.
The study is published in the August issue of the Journal of Alzheimer's Disease.
Gradual Increase in Intensity
Dr. Smith, a kinesiologist, said he has long been interested in finding out whether exercise could be useful in helping people who already are experiencing memory problems that go beyond the usual lapses of memory associated with normal aging.
"We often recommend physical exercise for people diagnosed with MCI because it has been reported to produce cognitive benefits in healthy older adults. We wanted to see if it really could have a beneficial effect on brain function in MCI," he said.
Seventeen participants had MCI, and 18 were normal age-matched control particpants.In the study, Dr. Smith and his colleagues recruited community-dwelling older adults aged 60 to 88 years who reported that they engaged in fewer than 3 days of moderate-intensity physical activity per week.
All of the study participants underwent a comprehensive neuropsycholgical test battery before and after the exercise intervention. Among the tests were the Mini–Mental State Exam, the Rey Auditory Verbal Learning Test (AVLT), and the Mattis Dementia Rating Scale–2 (DRS).
In addition, alternate forms of the AVLT and the DRS were used at the pre- and postintervention test sessions.
The exercise component of the study consisted of 44 sessions of treadmill walking that were supervised by a qualified personal fitness trainer during a period of 12 weeks.
The exercise intensity, session duration, and weekly frequency were gradually increased during the first 4 weeks until the participants were walking 30 minutes per session 4 times a week at an intensity of approximately 50% to 60% of heart rate reserve during weeks 5 to 12.
Both MCI and control participants significantly increased their cardiorespiratory fitness, as shown by improvement in peak aerobic capacity (VO2peak), by approximately 10% (P = .004) from baseline.
The researchers also found that memory scores on the AVLT test, which required that participants repeat a list of 15 words that was read to them, significantly improved among the MCI participants (P = .006) from baseline.
"The MCI group improved with the exercise. Before the intervention, they could remember 4 words, and after, this went up to 5 words, which was a significant improvement for them," Dr. Smith said.
"They are not losing memory like they were before. It is quite remarkable, in fact, because these people are expected to continue to lose memory function, and we showed that we could reverse that."
Slow Progression to Alzheimer's?
Exercise could benefit cognitive function a number of ways, Dr. Smith said.
"It's difficult to know for sure, and exercise affects every system in the body almost simultaneously, so to try to isolate what exactly is going on is difficult."
Studies in animals suggest that neurogenic and neurotrophic factors increase brain tissue growth. These growth factors can cause new synapses to form in the brain.
"This has been particularly shown to happen in the hippocampus, the part of the brain that is affected in Alzheimer's disease. Exercise has been shown to increase the size of the hippocampus, so that may be part of the reason for the improvement in memory," Dr. Smith said.
The improvement may also be due to increased blood flow and blood volume in the brain, which would boost the health of the neurons and bring them more nutrients.
The increased blood flow may also help to counteract the buildup of amyloid plaque that occurs in Alzheimer's disease, he said.
Encouraged by these results, Dr. Smith said he and his team plan to do this study in a larger group of people and to follow them for a longer period.
"Our hope is to see whether or not the exercise can actually slow down their progression to Alzheimer's disease and perhaps even prevent them from being diagnosed with Alzheimer's disease," he said.
Healthy Lifestyle Message
Commenting on this study for Medscape Medical News, Karen Miller, PhD, from the University of California, Los Angeles (UCLA) Longevity Center, said the study "is a worthwhile publication, as it extends our scientific knowledge on how lifestyle changes, including exercise, can promote brain fitness even among those with mild memory problems who are often at the greatest risk for developing dementia."
Dr. Miller added that the take-home message from this study is that individuals need to look at all aspects of their life "to promote better cognition and memory, including reducing vascular risk factors by controlling high blood pressure, increasing exercise, eating brain-healthy foods such as foods containing antioxidants, and participating in cognitively stimulating activities, such as taking a class, doing computerized brain fitness programs, and learning a foreign language."
Dr. Smith reports no relevant financial relationships. Dr. Miller reports that she is a consultant to Dakim, Inc., a producer of brain fitness computer programs.
J Alzheimers Dis. In press, 2013. Abstract

HRT Use: New Guidelines From the British Menopause Society


Laurie Barclay, MD
May 24, 2013
 
The British Menopause Society (BMS) and Women's Health Concern has issued updated guidelines on hormone replacement therapy (HRT) to clarify its use, benefits, and risks. The new recommendations, intended to complement the BMS Observations and Recommendations on menopause, were published online May 24 and in the June print issue ofMenopause International.

"Our aim is to provide helpful and pragmatic guidelines for health professionals involved in prescribing HRT and for women considering or currently using HRT," lead author Nick Panay, BMS chair, said in a news release. "With these updated recommendations, it is hoped that HRT will once again be used appropriately and provide benefits for many women in their menopause."
When first introduced more than a decade ago, HRT was considered to be the "elixir of youth," but accumulating evidence has highlighted associated risks precluding widespread use. Findings from the Women's Health Initiative in 2002 and the Million Women study in 2003 made use of HRT controversial, despite the known benefits. The evidence base for the new guidelines includes a reanalysis of the Women's Health Initiative and Million Women study trials and additional studies.
The updated recommendations provide advice regarding optimizing the menopause transition and beyond, using lifestyle and dietary interventions, complementary therapies, and HRT.
Key Recommendations
  • After receiving sufficient information from her health professional to make a fully informed choice, each woman should decide whether to use HRT.
  • The clinician should individualize the HRT dosage, regimen, and duration and reassess risks and benefits annually.
  • One of the main indications for HRT in postmenopausal women is relief of vasomotor symptoms, which are most effectively relieved by estrogen.
  • If menopausal symptoms persist, the benefits of HRT usually outweigh the risks. Therefore, the duration of HRT usage should not be subject to arbitrary limits.
  • When prescribed to women younger than 60 years, HRT has a favorable benefit/risk profile.
  • Women with premature ovarian insufficiency must be encouraged to use HRT, at least until the average age of the menopause.
  • If women older than 60 years opt for HRT, they should start with lower doses, preferably via the transdermal route.
  • Routine management of all women in the menopause transition and beyond should include optimization of diet and lifestyle.
  • Pharmacological alternatives to HRT may include selective serotonin reuptake inhibitors such as fluoxetine and paroxetine for vasomotor symptoms, venlafaxine, gabapentin, and possibly clonidine.
  • Phytoestrogens offer some benefits for symptom relief and on the skeletal and cardiovascular systems.
"It is imperative that in our ageing population research and development of increasingly sophisticated hormonal preparations should continue to maximize benefits and minimise side effects and risks," the guidelines authors conclude.
"This will optimise quality of life and facilitate the primary prevention of long-term conditions which create a personal, social and economic burden."
Menopause Int. Published online May 24, 2013. Full text

William Li: Can we eat to starve cancer?


William Li presents a new way to think about treating cancer and other diseases: anti-angiogenesis, preventing the growth of blood vessels that feed a tumor. 
The crucial first (and best) step: Eating cancer-fighting foods that cut off the supply lines and beat cancer at its own game.
William Li heads the Angiogenesis Foundation, a nonprofit that is re-conceptualizing global disease fighting. Full bio »

Sunday, August 11, 2013

Statins Linked With Risk of Musculoskeletal Injury


Michael O'Riordan

Jun 05, 2013
"These findings are concerning because starting statin therapy at a young age for primary prevention of cardiovascular diseases has been widely advocated," report Dr Ishak Mansi(VA North Texas Health Care System, Dallas) and colleagues in a paper published online June 3, 2013 in the Journal of the American Medical Association: Internal Medicine. "Moreover, the numbers needed to be exposed for one additional person to be harmed were 37 to 58 individuals for various outcomes."
The study included 6967 statin users propensity-matched with 6967 nonusers. Of the statin users, the majority was treated with simvastatin (73.5%) and approximately one-third had been prescribed maximum doses of the drugs, including simvastatin 80 mg, atorvastatin 80 mg, or rosuvastatin(Crestor, AstraZeneca) 40 mg. Simvastatin 80 mg is currently restricted on the US market because of concerns about muscle damage.
In the propensity-matched analysis, treatment with a statin was associated with a 19% increased risk of any type of musculoskeletal injury (p<0.001), a 13% increased risk of dislocations, strains, and sprains (p=0.001), and a 9% increased risk of musculoskeletal pain (p=0.02). There was a trend toward a 7% higher risk of osteoarthritis/arthropathies, but the association was not statistically significant in the propensity-matched analysis. There was an increased risk of osteoarthritis/arthropathies in two analyses that first adjusted for and then excluded patients with comorbidities at baseline.
In contrast, researchers observed no association between the number of years an individual took simvastatin and the risk of musculoskeletal injuries.
The group says that musculoskeletal adverse events with statins may represent a lesser known side effect of the drug class and should be studied further, especially in individuals who continue to be physically active. A better understanding of the full risks of statins will also "provide more complete data for cost/benefit and cost-effectiveness analyses of statin use," write Mansi et al.